Business Context and Reporting Period
This Form 8-K filing by WEX Inc. (WEX) was submitted on September 10, 2019, reporting a corporate governance event. The company is incorporated in Delaware and its common stock trades on the New York Stock Exchange under the symbol WEX.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The primary material change reported is a leadership transition within the WEX Health division:
- Resignation: Jeff Young resigned as President of WEX Health, effective immediately on September 10, 2019.
- Transition: Mr. Young will remain employed in a non-executive officer role during a transition period and expects to depart the company in October 2019.
- Appointment: Robert Deshaies assumed the title of President, WEX Health, effective September 10, 2019.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on financial performance, or discussion of risks and contingencies. The document is limited to the disclosure of the officer departure and appointment under Item 5.02.
Key Facts for Investor Verification
- Confirm the effective date of Robert Deshaies' appointment as President of WEX Health.
- Verify the expected departure date of Jeff Young from WEX Inc.
- Review subsequent filings for any impact of this leadership change on WEX Health's strategic direction or financial results.